pioglitazone has been researched along with berberine in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Joly, E; Lamontagne, J; Madiraju, SR; Nolan, CJ; Pepin, E; Peyot, ML; Poitout, V; Prentki, M; Ruderman, NB | 1 |
| Adil, M; Kandhare, AD; Mansoori, MN; Sharma, M; Singh, D | 1 |
| Chang, X; Gao, J; Ma, S; Wang, L; Wu, W; Xia, M; Yan, H | 1 |
| Asano, T; Endo, T; Iwasaki, N; Kadoya, K; Maenaka, K; Nakagawa, S; Otsuguro, S; Sotome, A; Suzuki, Y; Yuan, R | 1 |
1 trial(s) available for pioglitazone and berberine
| Article | Year |
|---|---|
Gender differences in the efficacy of pioglitazone treatment in nonalcoholic fatty liver disease patients with abnormal glucose metabolism.
Topics: Berberine; Diabetes Mellitus, Type 2; Female; Glucose; Humans; Male; Non-alcoholic Fatty Liver Disease; Pioglitazone; Sex Characteristics; Sex Factors | 2021 |
4 other study(ies) available for pioglitazone and berberine
| Article | Year |
|---|---|
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Pioglitazone acutely reduces insulin secretion and causes metabolic deceleration of the pancreatic beta-cell at submaximal glucose concentrations.
Topics: Adenosine Triphosphate; Animals; Berberine; Cell Line; Fatty Acids; Glucose; Hypoglycemic Agents; Immunoblotting; In Vitro Techniques; Insulin; Insulin Secretion; Insulin-Secreting Cells; Islets of Langerhans; Lipid Metabolism; Membrane Potential, Mitochondrial; Metformin; Pioglitazone; Pyrazoles; Pyrimidines; Rats; Rats, Wistar; Thiazolidinediones | 2009 |
Pioglitazone-induced bone loss in diabetic rats and its amelioration by berberine: A portrait of molecular crosstalk.
Topics: Animals; Berberine; Biomarkers; Blood Glucose; Bone and Bones; Bone Density; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Glycated Hemoglobin; Insulin; Male; Osteocalcin; Osteoporosis; Pioglitazone; PPAR gamma; Rats; Rats, Wistar; RNA, Messenger; Streptozocin; Thiazolidinediones | 2017 |
High-Throughput Screening Assay Identifies Berberine and Mubritinib as Neuroprotection Drugs for Spinal Cord Injury via Blood-Spinal Cord Barrier Protection.
Topics: Animals; Berberine; Endothelial Cells; High-Throughput Screening Assays; Humans; Hydrogen Peroxide; Mice; Neuroprotection; Neuroprotective Agents; Pioglitazone; Recovery of Function; Reproducibility of Results; Spinal Cord; Spinal Cord Injuries | 2022 |